scispace - formally typeset
S

Sadik C. Esener

Researcher at Oregon Health & Science University

Publications -  408
Citations -  8223

Sadik C. Esener is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Optical amplifier & Very-large-scale integration. The author has an hindex of 44, co-authored 407 publications receiving 7658 citations. Previous affiliations of Sadik C. Esener include Laval University & University of California, San Diego.

Papers
More filters
Journal ArticleDOI

Comparison between optical and electrical interconnects based on power and speed considerations

TL;DR: Conditions are determined for which optical interconnects can transmit information at a higher data rate and consume lc3s power than the equivalent electrical interconnections.
Journal ArticleDOI

Acoustic Droplet Vaporization and Propulsion of Perfluorocarbon‐Loaded Microbullets for Targeted Tissue Penetration and Deformation

TL;DR: Acoustic droplet vaporization of perfluorocarbon-loaded microbullets triggered by an ultrasound pulse provides the necessary force to penetrate, cleave, and deform cellular tissue for potential targeted drug delivery and precision nanosurgery.
Journal ArticleDOI

Sonogenetics is a non-invasive approach to activating neurons in Caenorhabditis elegans

TL;DR: The use of low-pressure ultrasound as a non-invasive trigger to activate specific ultrasonically sensitized neurons in the nematode, Caenorhabditis elegans is demonstrated and it is suggested that this method can be broadly applied to manipulate cellular functions in vivo.
Journal ArticleDOI

Rapid Isolation and Detection of Exosomes and Associated Biomarkers from Plasma

TL;DR: The ability of an alternating current electrokinetic (ACE) microarray chip device to rapidly isolate and recover glioblastoma exosomes from undiluted human plasma samples is demonstrated.
Journal ArticleDOI

Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells.

TL;DR: Anti-carcinoembryonic antigen half-antibody conjugated lipid-polymer hybrid nanoparticles are synthesized and characterized and show enhanced cancer killing effect compared to the corresponding nontargeted nanoparticles.